Earnings Call · Q2 FY2024·2024-08-07

Q2 24EPS +13.04%·Rev n/aQ1 24EPS +2.44%·Rev n/aQ4 23EPS +9.09%·Rev n/aQ3 23EPS +6.67%·Rev n/a⚠ consensus missing

BIODESIX INC BDSX

Chris Brinzey — Investor Relations

Scott Hutton — Chief Executive Officer

Robin Harper Cowie — Chief Financial Officer

+3.1%1d on move date+0.8% vs SPY3d+1.3%5d+8.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BDSX calls or request research access.

More BDSX calls Browse calls Request research access